Allworth Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-620
| Closed | -$7.72K | – | 4220 |
|
|
2024
Q4 | $7.72K | Hold |
620
| – | – | ﹤0.01% | 2559 |
|
|
2024
Q3 | $7.06K | Hold |
620
| – | – | ﹤0.01% | 2418 |
|
|
2024
Q2 | $5.86K | Buy |
620
+165
| +36% | +$1.26K | ﹤0.01% | 2449 |
|
|
2024
Q1 | $3.05K | Hold |
455
| – | – | ﹤0.01% | 2625 |
|
|
2023
Q4 | $2.96K | Buy |
455
+426
| +1,469% | +$2.75K | ﹤0.01% | 2497 |
|
|
2023
Q3 | $274 | Hold |
29
| – | – | ﹤0.01% | 3188 |
|
|
2023
Q2 | $406 | Sell |
29
-62
| -68% | -$1.06K | ﹤0.01% | 2934 |
|
|
2023
Q1 | $1.71K | Buy |
91
+62
| +214% | +$1.02K | ﹤0.01% | 2468 |
|
|
2022
Q4 | $399 | Hold |
29
| – | – | ﹤0.01% | 2687 |
|
|
2022
Q3 | $1K | Sell |
29
-686
| -96% | -$12.5K | ﹤0.01% | 2572 |
|
|
2022
Q2 | $11K | Hold |
715
| – | – | ﹤0.01% | 1558 |
|
|
2022
Q1 | $15K | Hold |
715
| – | – | ﹤0.01% | 1370 |
|
|
2021
Q4 | $21K | Buy |
715
+29
| +4% | +$830 | ﹤0.01% | 1112 |
|
|
2021
Q3 | $15K | Hold |
686
| – | – | ﹤0.01% | 1135 |
|
|
2021
Q2 | $18K | Hold |
686
| – | – | ﹤0.01% | 888 |
|
|
2021
Q1 | $13K | Hold |
686
| – | – | ﹤0.01% | 921 |
|
|
2020
Q4 | $8K | Hold |
686
| – | – | ﹤0.01% | 901 |
|
|
2020
Q3 | $5K | Hold |
686
| – | – | ﹤0.01% | 863 |
|
|
2020
Q2 | $5K | Hold |
686
| – | – | ﹤0.01% | 884 |
|
|
2020
Q1 | $4K | Hold |
686
| – | – | ﹤0.01% | 949 |
|
|
2019
Q4 | $5K | Hold |
686
| – | – | ﹤0.01% | 778 |
|
|
2019
Q3 | $4K | Hold |
686
| – | – | ﹤0.01% | 735 |
|
|
2019
Q2 | $4K | Hold |
686
| – | – | ﹤0.01% | 724 |
|
|
2019
Q1 | $3K | Hold |
686
| – | – | ﹤0.01% | 795 |
|
|
2018
Q4 | $3K | Hold |
686
| – | – | ﹤0.01% | 706 |
|
|
2018
Q3 | $5K | Hold |
686
| – | – | ﹤0.01% | 668 |
|
|
2018
Q2 | $3K | Hold |
686
| – | – | ﹤0.01% | 757 |
|
|
2018
Q1 | $2K | Hold |
686
| – | – | ﹤0.01% | 732 |
|
|
2017
Q4 | $3K | Hold |
686
| – | – | ﹤0.01% | 641 |
|
|
2017
Q3 | $2K | Buy |
+686
| New | +$2.58K | ﹤0.01% | 677 |
|
|
2017
Q2 | – | Sell |
-686
| Closed | -$3K | – | 833 |
|
|
2017
Q1 | $3K | Hold |
686
| – | – | ﹤0.01% | 620 |
|
|
2016
Q4 | $1K | Hold |
686
| – | – | ﹤0.01% | 649 |
|
|
2016
Q3 | $2K | Hold |
686
| – | – | ﹤0.01% | 608 |
|
|
2016
Q2 | $2K | Buy |
+686
| New | +$1.91K | ﹤0.01% | 565 |
|
Other funds holding CDMO
Allworth Financial's CDMO Position: Q1 2025 in Review
Allworth Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 620 shares — an estimated $7.72K sold.
Allworth Financial first reported a position in CDMO in Q2 2016 and held it in 34 quarters. The position peaked at $21K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Allworth Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Allworth Financial sold 620 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $7.72K.
- Allworth Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2016 and held it in 34 quarters.
- Allworth Financial's Avid Bioservices, Inc. Common Stock position peaked at $21K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Allworth Financial's 13F filing for Q1 2025, filed 30 Apr 2025.